Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2018 Jul 4

PMID 29966306

Citations 21

Authors

Aleksandra Marchwicka

Ewa Marcinkowska

Affiliations

Soon will be listed here.

Abstract

All-trans-retinoic acid (ATRA) and 1α,25-dihydroxyvitamin D (1,25D) are potent inducers of differentiation of myeloid leukemia cells. During myeloid differentiation specific transcription factors are expressed at crucial developmental stages. However, precise mechanism controlling the diversification of myeloid progenitors is largely unknown, CCAAT/enhancer-binding protein (C/EBP) transcription factors have been characterized as key regulators of the development and function of the myeloid system. Past data point at functional redundancy among C/EBP family members during myeloid differentiation. In this study, we show that in acute myeloid leukemia (AML) cells, high expression of vitamin D receptor gene () is needed for strong and sustained upregulation of gene, while the moderate expression of is sufficient for upregulation of in response to 1,25D. The high expression level of the gene encoding for retinoic acid receptor α () allows for high and sustained expression of , which becomes decreased along with a decrease of expression. Expression of induced by ATRA is accompanied by upregulated expression of with similar kinetics. Our results suggest that is the major VDR and RARA-responsive gene among the family, necessary for expression of genes connected with myeloid functions.

Citing Articles

Identification of C/EBPδ-Modifying Compounds as Potential Anticancer Agents Using a High-Throughput Drug Screen.

Hartl L, Duitman J, Aberson H, Medema J, Bijlsma M, Spek C J Cell Mol Med. 2025; 29(3):e70287.

PMID: 39887610 PMC: 11783153. DOI: 10.1111/jcmm.70287.

A metabolic perspective of the neutrophil life cycle: new avenues in immunometabolism.

Thind M, Uhlig H, Glogauer M, Palaniyar N, Bourdon C, Gwela A Front Immunol. 2024; 14:1334205.

PMID: 38259490 PMC: 10800387. DOI: 10.3389/fimmu.2023.1334205.

Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.

Ozgun G, Yaras T, Akman B, Ozden-Yilmaz G, Landman N, Karakulah G Cancer Gene Ther. 2024; 31(4):537-551.

PMID: 38233533 DOI: 10.1038/s41417-024-00725-3.

YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.

Noguera N, Travaglini S, Scalea S, Catalanotto C, Reale A, Zampieri M Cancers (Basel). 2023; 15(15).

PMID: 37568827 PMC: 10417667. DOI: 10.3390/cancers15154010.

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Rodriguez-Zabala M, Ramakrishnan R, Reinbach K, Ghosh S, Oburoglu L, Falques-Costa A Blood Adv. 2023; 7(18):5382-5395.

PMID: 37505194 PMC: 10509671. DOI: 10.1182/bloodadvances.2023009967.

References

Pham T, Langmann S, Schwarzfischer L, El Chartouni C, Lichtinger M, Klug M . CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J Biol Chem. 2007; 282(30):21924-33. DOI: 10.1074/jbc.M611618200. View

Nerlov C . The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007; 17(7):318-24. DOI: 10.1016/j.tcb.2007.07.004. View

Morosetti R, Park D, Chumakov A, Grillier I, Shiohara M, Gombart A . A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood. 1997; 90(7):2591-600. View

Cilloni D, Carturan S, Gottardi E, Messa F, Messa E, Fava M . Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias. Blood. 2003; 102(7):2705-6. DOI: 10.1182/blood-2003-07-2256. View

Dhawan P, Peng X, Sutton A, MacDonald P, Croniger C, Trautwein C . Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol. 2004; 25(1):472-87. PMC: 538756. DOI: 10.1128/MCB.25.1.472-487.2005. View

Heath V, Suh H, Holman M, Renn K, Gooya J, Parkin S . C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood. 2004; 104(6):1639-47. DOI: 10.1182/blood-2003-11-3963. View

Taskesen E, Bullinger L, Corbacioglu A, Sanders M, Erpelinck C, Wouters B . Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood. 2010; 117(8):2469-75. DOI: 10.1182/blood-2010-09-307280. View

Ford A, Bennett C, Healy L, Towatari M, Greaves M, Enver T . Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification. Proc Natl Acad Sci U S A. 1996; 93(20):10838-43. PMC: 38242. DOI: 10.1073/pnas.93.20.10838. View

Ades L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S . Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood. 2009; 115(9):1690-6. DOI: 10.1182/blood-2009-07-233387. View

10.

Bullinger L, Dohner K, Dohner H . Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. J Clin Oncol. 2017; 35(9):934-946. DOI: 10.1200/JCO.2016.71.2208. View

11.

Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y . Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997; 16(4):391-6. DOI: 10.1038/ng0897-391. View

12.

Scott L, Civin C, Rorth P, Friedman A . A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood. 1992; 80(7):1725-35. View

13.

Fujiki A, Imamura T, Sakamoto K, Kawashima S, Yoshida H, Hirashima Y . All-trans retinoic acid combined with 5-Aza-2'-deoxycitidine induces C/EBPα expression and growth inhibition in MLL-AF9-positive leukemic cells. Biochem Biophys Res Commun. 2012; 428(2):216-23. DOI: 10.1016/j.bbrc.2012.09.131. View

14.

Canete A, Cano E, Munoz-Chapuli R, Carmona R . Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis. Nutrients. 2017; 9(2). PMC: 5331590. DOI: 10.3390/nu9020159. View

15.

Dhawan P, Wieder R, Christakos S . CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J Biol Chem. 2008; 284(5):3086-3095. PMC: 2631956. DOI: 10.1074/jbc.M803602200. View

16.

Gocek E, Marchwicka A, Bujko K, Marcinkowska E . NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells. PLoS One. 2014; 9(3):e91752. PMC: 3958372. DOI: 10.1371/journal.pone.0091752. View

17.

HILLESTAD L . Acute promyelocytic leukemia. Acta Med Scand. 1957; 159(3):189-94. View

18.

Kahlen J, Carlberg C . Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter. Biochem Biophys Res Commun. 1994; 202(3):1366-72. DOI: 10.1006/bbrc.1994.2081. View

19.

Kastner P, Chan S . Function of RARalpha during the maturation of neutrophils. Oncogene. 2001; 20(49):7178-85. DOI: 10.1038/sj.onc.1204757. View

20.

Janik S, Nowak U, Laszkiewicz A, Satyr A, Majkowski M, Marchwicka A . Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation. Int J Mol Sci. 2017; 18(6). PMC: 5486144. DOI: 10.3390/ijms18061323. View